Teva Clinical Study Site 10099 — Seattle, Washington

Teva Clinical Study Site 10099 is a clinical research site located in Seattle, Washington, United States.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Teva Clinical Study Site 10099 has participated in 1 clinical trials.

Therapeutic areas: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Emphysema.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Clinical Study Site 10099?

Teva Clinical Study Site 10099 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Clinical Study Site 10099 conducted?

Teva Clinical Study Site 10099 has 1 clinical trials on record. Their work covers Asthma, Chronic Obstructive Pulmonary Disease (COPD), Emphysema.

Is Teva Clinical Study Site 10099 accredited by Crixeo Health?

Teva Clinical Study Site 10099 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Clinical Study Site 10099?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.